Dr Fadi Bailony, MD | |
7991 Beechmont Ave Ste A, Cincinnati, OH 45255-3191 | |
(513) 528-5600 | |
Not Available |
Full Name | Dr Fadi Bailony |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 28 Years |
Location | 7991 Beechmont Ave Ste A, Cincinnati, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003965385 | NPI | - | NPPES |
2378476 | Medicaid | OH | |
P00884534 | Other | OH | RR MEDICARE |
64067614 | Medicaid | KY | |
200987700 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 37870 (Kentucky) | Secondary |
208M00000X | Hospitalist | 35-080473 (Ohio) | Secondary |
207R00000X | Internal Medicine | 35080473 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bethesda North | Cincinnati, OH | Hospital |
Good Samaritan Hospital | Cincinnati, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Trihealth G Llc | 0749222651 | 253 |
News Archive
An international team of scientists led from Sweden's Karolinska Institutet has for the first time mapped all the genes that are activated in the first few days of a fertilized human egg. The study, which is being published in the journal Nature Communications, provides an in-depth understanding of early embryonic development in human - and scientists now hope that the results will help finding for example new therapies against infertility.
Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, can significantly reduce or even eliminate their need for expensive and time-consuming apheresis treatments with the PCSK9 inhibitor alirocumab.
The era of one-size-fits-all medicine will eventually be history; after all it is no news that drugs and treatments do not work the same for everyone. For patients with nonsmall cell lung cancer, a lung cancer that kills approximately 1 million people annually, the treatment currently available is basically the same for all patients, despite the fact that some patients may respond to treatment while others may not.
NewBridge announced the close of $12 million in Series B financing, bringing the total amount raised to-date to $16 million. The Series B round was led by Kuwait Life Sciences Company, a subsidiary of National Technology Enterprises Company of Kuwait with participation by the previous investor Burrill Life Sciences Capital Fund III, L.P.
› Verified 3 days ago
Entity Name | Trihealth G Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295862944 PECOS PAC ID: 0749222651 Enrollment ID: O20050601000358 |
News Archive
An international team of scientists led from Sweden's Karolinska Institutet has for the first time mapped all the genes that are activated in the first few days of a fertilized human egg. The study, which is being published in the journal Nature Communications, provides an in-depth understanding of early embryonic development in human - and scientists now hope that the results will help finding for example new therapies against infertility.
Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, can significantly reduce or even eliminate their need for expensive and time-consuming apheresis treatments with the PCSK9 inhibitor alirocumab.
The era of one-size-fits-all medicine will eventually be history; after all it is no news that drugs and treatments do not work the same for everyone. For patients with nonsmall cell lung cancer, a lung cancer that kills approximately 1 million people annually, the treatment currently available is basically the same for all patients, despite the fact that some patients may respond to treatment while others may not.
NewBridge announced the close of $12 million in Series B financing, bringing the total amount raised to-date to $16 million. The Series B round was led by Kuwait Life Sciences Company, a subsidiary of National Technology Enterprises Company of Kuwait with participation by the previous investor Burrill Life Sciences Capital Fund III, L.P.
› Verified 3 days ago
Entity Name | Medicine Inpatient Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326227307 PECOS PAC ID: 3577645340 Enrollment ID: O20080201000076 |
News Archive
An international team of scientists led from Sweden's Karolinska Institutet has for the first time mapped all the genes that are activated in the first few days of a fertilized human egg. The study, which is being published in the journal Nature Communications, provides an in-depth understanding of early embryonic development in human - and scientists now hope that the results will help finding for example new therapies against infertility.
Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, can significantly reduce or even eliminate their need for expensive and time-consuming apheresis treatments with the PCSK9 inhibitor alirocumab.
The era of one-size-fits-all medicine will eventually be history; after all it is no news that drugs and treatments do not work the same for everyone. For patients with nonsmall cell lung cancer, a lung cancer that kills approximately 1 million people annually, the treatment currently available is basically the same for all patients, despite the fact that some patients may respond to treatment while others may not.
NewBridge announced the close of $12 million in Series B financing, bringing the total amount raised to-date to $16 million. The Series B round was led by Kuwait Life Sciences Company, a subsidiary of National Technology Enterprises Company of Kuwait with participation by the previous investor Burrill Life Sciences Capital Fund III, L.P.
› Verified 3 days ago
Entity Name | Mavail Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790416303 PECOS PAC ID: 7810362258 Enrollment ID: O20230417001469 |
News Archive
An international team of scientists led from Sweden's Karolinska Institutet has for the first time mapped all the genes that are activated in the first few days of a fertilized human egg. The study, which is being published in the journal Nature Communications, provides an in-depth understanding of early embryonic development in human - and scientists now hope that the results will help finding for example new therapies against infertility.
Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, can significantly reduce or even eliminate their need for expensive and time-consuming apheresis treatments with the PCSK9 inhibitor alirocumab.
The era of one-size-fits-all medicine will eventually be history; after all it is no news that drugs and treatments do not work the same for everyone. For patients with nonsmall cell lung cancer, a lung cancer that kills approximately 1 million people annually, the treatment currently available is basically the same for all patients, despite the fact that some patients may respond to treatment while others may not.
NewBridge announced the close of $12 million in Series B financing, bringing the total amount raised to-date to $16 million. The Series B round was led by Kuwait Life Sciences Company, a subsidiary of National Technology Enterprises Company of Kuwait with participation by the previous investor Burrill Life Sciences Capital Fund III, L.P.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Fadi Bailony, MD 7991 Beechmont Ave Ste A, Cincinnati, OH 45255-3191 Ph: (513) 528-5600 | Dr Fadi Bailony, MD 7991 Beechmont Ave Ste A, Cincinnati, OH 45255-3191 Ph: (513) 528-5600 |
News Archive
An international team of scientists led from Sweden's Karolinska Institutet has for the first time mapped all the genes that are activated in the first few days of a fertilized human egg. The study, which is being published in the journal Nature Communications, provides an in-depth understanding of early embryonic development in human - and scientists now hope that the results will help finding for example new therapies against infertility.
Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, can significantly reduce or even eliminate their need for expensive and time-consuming apheresis treatments with the PCSK9 inhibitor alirocumab.
The era of one-size-fits-all medicine will eventually be history; after all it is no news that drugs and treatments do not work the same for everyone. For patients with nonsmall cell lung cancer, a lung cancer that kills approximately 1 million people annually, the treatment currently available is basically the same for all patients, despite the fact that some patients may respond to treatment while others may not.
NewBridge announced the close of $12 million in Series B financing, bringing the total amount raised to-date to $16 million. The Series B round was led by Kuwait Life Sciences Company, a subsidiary of National Technology Enterprises Company of Kuwait with participation by the previous investor Burrill Life Sciences Capital Fund III, L.P.
› Verified 3 days ago
Moises Arturo Huaman Joo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman Street, Cincinnati, OH 45219 Phone: 513-584-6977 Fax: 513-584-4281 | |
Dr. Kiranmayee Lanka, M.D., M.P.H Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2123 Auburn Ave, Suite 401, Cincinnati, OH 45219 Phone: 513-241-5489 Fax: 513-241-5490 | |
Dr. Saurabh Chandra, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 234 Goodman St, Cincinnati, OH 45219 Phone: 513-558-1000 | |
Gretchen Suarez, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10500 Montgomery Rd, Cincinnati, OH 45242 Phone: 513-865-2246 Fax: 513-865-5596 | |
Dr. Andrew Michael Espinal, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4777 E Galbraith Rd, Cincinnati, OH 45236 Phone: 513-686-3000 | |
Sorina M Macavei, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 463 Ohio Pike, Suite 300, Cincinnati, OH 45255 Phone: 513-528-5600 Fax: 513-528-9716 | |
Helen K Koselka, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3219 Clifton Ave, Suite 100, Cincinnati, OH 45220 Phone: 513-528-5600 Fax: 513-528-9716 |